142 related articles for article (PubMed ID: 17581265)
21. Effect of gluten-free diet on preventing recurrence of gastroesophageal reflux disease-related symptoms in adult celiac patients with nonerosive reflux disease.
Usai P; Manca R; Cuomo R; Lai MA; Russo L; Boi MF
J Gastroenterol Hepatol; 2008 Sep; 23(9):1368-72. PubMed ID: 18853995
[TBL] [Abstract][Full Text] [Related]
22. Oral pH-modified release budesonide for treatment of inflammatory bowel disease, collagenous and lymphocytic colitis.
Gross V
Expert Opin Pharmacother; 2008 May; 9(7):1257-65. PubMed ID: 18422482
[TBL] [Abstract][Full Text] [Related]
23. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients.
Ribi C; Cohen P; Pagnoux C; Mahr A; Arène JP; Lauque D; Puéchal X; Letellier P; Delaval P; Cordier JF; Guillevin L;
Arthritis Rheum; 2008 Feb; 58(2):586-94. PubMed ID: 18240234
[TBL] [Abstract][Full Text] [Related]
24. Adult celiac disease followed by onset of systemic lupus erythematosus.
Freeman HJ
J Clin Gastroenterol; 2008 Mar; 42(3):252-5. PubMed ID: 18223501
[TBL] [Abstract][Full Text] [Related]
25. Azathioprine in refractory sprue.
Vaidya A; Bolanos J; Berkelhammer C
Am J Gastroenterol; 1999 Jul; 94(7):1967-9. PubMed ID: 10406270
[TBL] [Abstract][Full Text] [Related]
26. Use of pharmacogenetics, enzymatic phenotyping, and metabolite monitoring to guide treatment with azathioprine in patients with systemic lupus erythematosus.
Askanase AD; Wallace DJ; Weisman MH; Tseng CE; Bernstein L; Belmont HM; Seidman E; Ishimori M; Izmirly PM; Buyon JP
J Rheumatol; 2009 Jan; 36(1):89-95. PubMed ID: 19040311
[TBL] [Abstract][Full Text] [Related]
27. [Frequency of celiac disease and irritable bowel syndrome coexistance and its influence on the disease course].
Zwolińska-Wcisło M; Galicka-Latała D; Rozpondek P; Rudnicka-Sosin L; Mach T
Przegl Lek; 2009; 66(3):126-9. PubMed ID: 19689036
[TBL] [Abstract][Full Text] [Related]
28. Long-term effects of budesonide on inflammatory status in COPD.
Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
COPD; 2008 Apr; 5(2):97-104. PubMed ID: 18415808
[TBL] [Abstract][Full Text] [Related]
29. What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis.
Hopper AD; Hadjivassiliou M; Hurlstone DP; Lobo AJ; McAlindon ME; Egner W; Wild G; Sanders DS
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):314-20. PubMed ID: 18328437
[TBL] [Abstract][Full Text] [Related]
30. A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects.
Martínez-Taboada VM; Rodríguez-Valverde V; Carreño L; López-Longo J; Figueroa M; Belzunegui J; Mola EM; Bonilla G
Ann Rheum Dis; 2008 May; 67(5):625-30. PubMed ID: 18086726
[TBL] [Abstract][Full Text] [Related]
31. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
Kopriva F; Dzubak P; Potesil J; Hajduch M
J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671
[TBL] [Abstract][Full Text] [Related]
32. High rates of complications and substantial mortality in both types of refractory sprue.
Daum S; Ipczynski R; Schumann M; Wahnschaffe U; Zeitz M; Ullrich R
Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):66-70. PubMed ID: 19011576
[TBL] [Abstract][Full Text] [Related]
33. How many duodenal biopsy specimens are required to make a diagnosis of celiac disease?
Pais WP; Duerksen DR; Pettigrew NM; Bernstein CN
Gastrointest Endosc; 2008 Jun; 67(7):1082-7. PubMed ID: 18308317
[TBL] [Abstract][Full Text] [Related]
34. Enteric-Release Budesonide May Be Useful in the Management of Non-Responsive Celiac Disease.
Therrien A; Silvester JA; Leonard MM; Leffler DA; Fasano A; Kelly CP
Dig Dis Sci; 2021 Jun; 66(6):1989-1997. PubMed ID: 32654085
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of Enteric-Release Oral Budesonide in Treatment of Acute Reactions to Gluten in Patients With Celiac Disease.
Therrien A; Silvester JA; Leffler DA; Kelly CP
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):254-256. PubMed ID: 30905717
[TBL] [Abstract][Full Text] [Related]
36. Small intestinal release mesalamine for the treatment of refractory celiac disease type I.
Jamma S; Leffler DA; Dennis M; Najarian RM; Schuppan DB; Sheth S; Kelly CP
J Clin Gastroenterol; 2011 Jan; 45(1):30-3. PubMed ID: 20871406
[TBL] [Abstract][Full Text] [Related]
37. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II.
Malamut G; Afchain P; Verkarre V; Lecomte T; Amiot A; Damotte D; Bouhnik Y; Colombel JF; Delchier JC; Allez M; Cosnes J; Lavergne-Slove A; Meresse B; Trinquart L; Macintyre E; Radford-Weiss I; Hermine O; Brousse N; Cerf-Bensussan N; Cellier C
Gastroenterology; 2009 Jan; 136(1):81-90. PubMed ID: 19014942
[TBL] [Abstract][Full Text] [Related]
38. Effect of disease duration on dose-response of inhaled budesonide in asthma.
Selroos O
Respir Med; 2008 Jul; 102(7):1065-72. PubMed ID: 18387797
[TBL] [Abstract][Full Text] [Related]
39. Management of sympathetic ophthalmia with the fluocinolone acetonide implant.
Mahajan VB; Gehrs KM; Goldstein DA; Fischer DH; Lopez JS; Folk JC
Ophthalmology; 2009 Mar; 116(3):552-557.e1. PubMed ID: 19147232
[TBL] [Abstract][Full Text] [Related]
40. Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era.
Gustavsson A; Halfvarson J; Magnuson A; Sandberg-Gertzén H; Tysk C; Järnerot G
Am J Gastroenterol; 2007 Nov; 102(11):2513-9. PubMed ID: 17680849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
